相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Test-retest characteristic of [18F]MK-6240 quantitative outcomes in cognitively normal adults and subjects with Alzheimer's disease
Cristian Salinas et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
Tobey J. Betthauser et al.
BRAIN (2020)
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects
Ruben Smith et al.
BRAIN (2020)
Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles
Talakad G. Lohith et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand F-18-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls
Tobey J. Betthauser et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample
Renaud La Joie et al.
NEUROLOGY (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal
Christopher M. Lee et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
In vivo quantification of neurofibrillary tangles with [18F]MK-6240
Tharick A. Pascoal et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers
Ivan Koychev et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer's disease
Anne-Laure Aziz et al.
NEUROBIOLOGY OF AGING (2017)
Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease
Hanna Cho et al.
NEUROBIOLOGY OF AGING (2017)
AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure
Shruti Mishra et al.
NEUROIMAGE (2017)
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
Anne Maass et al.
NEUROIMAGE (2017)
Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment
Santiago Bullich et al.
NEUROIMAGE-CLINICAL (2017)
Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update
Karim Farid et al.
NEUROIMAGE-CLINICAL (2017)
Distinct 18F-AV-1451 tau PET retention patterns in early-and late-onset Alzheimer's disease
Michael Scholl et al.
BRAIN (2017)
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
Niklas Mattsson et al.
EMBO MOLECULAR MEDICINE (2017)
[F-18]AV-1451 Positron Emission Tomography Retention in Choroid Plexus: More Than Off-Target Binding
Milos D. Ikonomovic et al.
ANNALS OF NEUROLOGY (2016)
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schoell et al.
NEURON (2016)
PART, a distinct tauopathy, different from classical sporadic Alzheimer disease
Kurt A. Jellinger et al.
ACTA NEUROPATHOLOGICA (2015)
Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review
Myria Petrou et al.
MOVEMENT DISORDERS (2015)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary et al.
ACTA NEUROPATHOLOGICA (2014)
[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
Chun-Fang Xia et al.
ALZHEIMERS & DEMENTIA (2013)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
Kerryn E. Pike et al.
NEUROPSYCHOLOGIA (2011)
In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand F-18-AV-45 (Flobetapir F 18)
Dean F. Wong et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease
Natalie Nelissen et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer:: proof of mechanism
Christopher C. Rowe et al.
LANCET NEUROLOGY (2008)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients
EJ Kim et al.
BRAIN (2005)
Simultaneous measurement of β-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
A Olsson et al.
CLINICAL CHEMISTRY (2005)
Controlling the false discovery rate in behavior genetics research
Y Benjamini et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
分享论文
